Japan's Takeda Reportedly Offering $12B For Europe's Nycomed
This article was originally published in The Pink Sheet Daily
Executive Summary
The deal, if confirmed, would boost Takeda's European and emerging markets presence, providing an additional €3.2 billion in revenues to help offset forthcoming patent expiries.